Canopy Rivers Inc Reveals $80M Loan Financing Arrangement

Canopy Rivers Inc. portfolio company, TerrAscend Corp has a loan financing arrangement with Canopy Growth Corporation

Canopy Rivers Inc. portfolio company, TerrAscend Corp. ("TerrAscend"), today announced that TerrAscend's wholly owned subsidiary, TerrAscend Canada Inc. ("TerrAscend Canada") has entered into an C$80.5 million loan financing arrangement with Canopy Growth Corporation pursuant to a secured debenture. In connection with the loan, TerrAscend has issued 17,808,975 common share purchase warrants to Canopy Growth. 

"This additional capital is a vote of confidence in TerrAscend Canada's ability to execute on its strategic mandate for both domestic and international markets," said Narbe Alexandrian, President and Chief Executive Officer, Canopy Rivers

"We believe the TerrAscend team is well-positioned through their resources and network to continue to take advantage of opportunities in regulated jurisdictions. We are also pleased with Canopy Growth's continued support of our portfolio companies."

The net proceeds are expected to be used by TerrAscend Canada for general corporate purposes and the funding of its Canadian operations, its Arise Bioscience U.S. hemp division, international expansion, and the repayment of indebtedness. The funds cannot be used, directly or indirectly, in connection with or for any cannabis or cannabis-related operations in the United States, unless and until such operations comply with all applicable laws of the United States.

Disclaimer: Past performance is not an indicator of future performance.


This could be one of the best investing opportunities of 2020

Legislative changes are blowing through the US, and with it, an ever-increasing number of states legalising cannabis for recreational use.

With the success seen in Illinois, which legalised for adult-use on January 1 and saw products moving off the shelf at an unprecedented rate, this company is primed to take advantage of the booming US recreational market.

They have secured partnerships with the biggest cannabis companies in the US, and their portfolio is second to none.

And with the sector-wide pullback of 2019, this company is now at a bargain-basement price.

Subscribe Now
& Keep Up to Date

Get the latest pot stock recommendations, cannabis news
and industry updates straight to your inbox!

Niki Mohazeb
Niki Mohazeb

Niki is a Sydney based writer, with a passion for promoting the health benefits of medicinal cannabis. Niki also enjoys researching and writing about the future of cannabis along with the many other benefits that the plant provides, such as the diverse utilities of hemp.

Leave a Reply

Your email address will not be published. Required fields are marked *